CP
STIM icon

CenterBook Partners’s Neuronetics STIM Stock Holding History

CenterBook Partners’s Portfolio STIM Stock Details STIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-106,650
Closed -$372K – 656
2025
Q2 		$372K Sell
106,650
-219,476
-67% -$866K 0.02% 474
2025
Q1 		$1.2M Buy
+326,126
New +$1.19M 0.08% 288

Other funds holding STIM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $690M AUM 57.92% 1-Year Est. Return
MCM
Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CenterBook Partners's STIM Position: Q3 2025 in Review

CenterBook Partners sold out of Neuronetics (STIM) in Q3 2025, closing a stake of 106,650 shares — an estimated $372K sold.

CenterBook Partners first reported a position in STIM in Q1 2025 and held it in 2 quarters. The position peaked at $1.2M in Q1 2025. 99 funds tracked by Wall St. Rank hold STIM as of Q3 2025.

  • CenterBook Partners reported no remaining Neuronetics position as of Q3 2025 after selling out during the quarter.
  • CenterBook Partners sold 106,650 Neuronetics shares in Q3 2025, an estimated $372K.
  • CenterBook Partners first reported a position in Neuronetics in Q1 2025 and held it in 2 quarters.
  • CenterBook Partners's Neuronetics position peaked at $1.2M in Q1 2025.
  • 99 funds tracked by Wall St. Rank held Neuronetics as of Q3 2025.

Based on CenterBook Partners's 13F filing for Q3 2025, filed 7 Nov 2025.